Effect of Uptitration of Recommended Heart Failure Medications on Restricted Mean Survival Time in STRONG-HF
JACC Heart Fail
.
2025 May;13(5):873-876.
doi: 10.1016/j.jchf.2025.02.020.
Authors
Ashok Krishnaswami
1
,
Beth A Davison
2
,
Christopher Edwards
3
,
Gad Cotter
2
,
Marco Metra
4
,
Ovidiu Chioncel
5
,
Karen Sliwa
6
,
Adriaan A Voors
7
,
Alexandre Mebazaa
8
,
Deepak L Bhatt
9
Affiliations
1
Kaiser Permanente San Jose Medical Center, San Jose, California, USA. Electronic address: ashok.krishnaswami@kp.org.
2
Heart Initiative, Durham, North Carolina, USA; Momentum Research Inc, Durham, North Carolina, USA; Université Paris Cité, Paris, France.
3
Momentum Research Inc, Durham, North Carolina, USA.
4
University of Brescia, Brescia, Italy.
5
University of Medicine "Carol Davila," Bucharest, Romania.
6
Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
7
University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
8
Université Paris Cité, Paris, France; Saint-Louis and Lariboisière Hospitals, Paris, France.
9
Mount Sinai Fuster Heart Hospital, Icahn School of Medicine, New York, New York, USA.
PMID:
40335239
DOI:
10.1016/j.jchf.2025.02.020
No abstract available
Publication types
Letter